BLUESTEIN R H & CO LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 145 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
BLUESTEIN R H & CO LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q1 2017$76,000
+18.8%
12,0000.0%0.01%
+25.0%
Q4 2016$64,000
-5.9%
12,0000.0%0.00%0.0%
Q3 2016$68,000
+3.0%
12,0000.0%0.00%
-20.0%
Q2 2016$66,000
-17.5%
12,000
+11.0%
0.01%
-16.7%
Q1 2016$80,000
-11.1%
10,8110.0%0.01%0.0%
Q4 2015$90,000
-7.2%
10,8110.0%0.01%
-14.3%
Q3 2015$97,000
-25.4%
10,8110.0%0.01%
-12.5%
Q2 2015$130,000
+20.4%
10,811
+8.1%
0.01%
+14.3%
Q1 2015$108,00010,0000.01%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q3 2016
NameSharesValueWeighting ↓
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 14,642,959$25,186,0003.76%
MSD Partners, L.P. 15,151,516$26,061,0002.11%
MSD Partners, L.P. 7,575,758$13,030,0001.05%
MAGNOLIA CAPITAL ADVISORS LLC 418,569$720,0000.61%
STEEL GROVE CAPITAL ADVISORS, LLC 1,080,000$1,858,0000.33%
EAM Investors, LLC 454,625$782,0000.17%
Allred Capital Management, LLC 158,000$271,0000.17%
Boxer Capital, LLC 1,500,000$2,580,0000.14%
GSA CAPITAL PARTNERS LLP 608,037$1,046,0000.14%
CHIRON CAPITAL MANAGEMENT, LLC 116,860$201,0000.14%
View complete list of ZIOPHARM ONCOLOGY INC shareholders